Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 100,217 |
|
|||||
| News | (3) | ||||||
| Day High | 86.90 | Low High |
|||||
| Day Low | 85.17 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Ligand Pharmaceuticals Incorporated | LGND | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 1.04 | 1.22% | 86.06 | 17:30:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 85.53 | 85.17 | 86.90 | 86.06 | 85.02 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 3,614 | 100,217 | $ 85.92 | $ 8,610,891 | - | 49.24 - 94.57 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:03:48 | 1 | $ 84.37 | USD |
Ligand Pharmaceuticals Incorporated Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.52B | 17.71M | - | 131.31M | 52.15M | 2.95 | 29.20 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Ligand Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical LGND Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 85.53 | 87.77 | 83.93 | 85.57 | 131,379 | 0.53 | 0.62% |
| 1 Month | 71.93 | 87.77 | 67.72 | 77.05 | 165,591 | 14.13 | 19.64% |
| 3 Months | 74.00 | 94.57 | 67.72 | 76.83 | 191,949 | 12.06 | 16.30% |
| 6 Months | 57.74 | 94.57 | 57.00 | 73.89 | 150,237 | 28.32 | 49.05% |
| 1 Year | 77.14 | 94.57 | 49.24 | 70.34 | 125,507 | 8.92 | 11.56% |
| 3 Years | 128.49 | 169.98 | 49.24 | 94.07 | 145,280 | -42.43 | -33.02% |
| 5 Years | 115.03 | 219.75 | 49.24 | 105.38 | 237,944 | -28.97 | -25.18% |
Ligand Pharmaceuticals Description
| Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material. |
